ArticleFundamental research2026
Data tells the truth: A Knowledge distillation method for genomic survival analysis by handling censoring.
Article in Fundamental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Survival analysis is a critical tool for cancer research, yet handling censored data remains challenging due to supervision bias and inaccurate hazard estimates. To address these issues, we propose a simple but effective method termed KD, which employs knowledge distillation using uncensored data to rectify the supervision bias in censored data. This approach leverages the combined power of both rectified censored data and uncensored data to improve survival prediction accuracy. Remarkably, our KD method not only effectively harnesses censored data but also better reflects clinical reality, demonstrating its immense value in survival analysis. We applied our KD method to 19 target cancer sites using The Cancer Genome Atlas (TCGA) dataset. Our results consistently outperform traditional machine learning and deep learning-based methods across both target cancer sites and independent cancer cohorts. More importantly, our data-driven approach enables the model to extract hidden information from censored data, leading to conclusions that align more closely with clinical knowledge and scenarios. This validation of our KD method's effectiveness highlights the substantial value of rational censored data usage, providing valuable insights for cancer research and clinical decisions. All data and codes are freely available at: https://datatellstruth.github.io/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.